Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predicting outcome in pollen immunotherapy
NL-OMON36093Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Mar 2012
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of five-grass-pollen extract in allergic rhinitis (AR) and seasonal allergic rhinitis (SAR), sponsored by Amsterdam University Medical Center. Started Mar 2012; status: active, not recruiting.
02
Drugs
five-grass-pollen extract
03
Conditions
allergic rhinitis (AR)seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NL-OMON36093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36093.